Vis enkel innførsel

dc.contributor.authorBrekke, Kurt Richard
dc.contributor.authorHolmås, Tor Helge
dc.contributor.authorStraume, Odd Rune
dc.date.accessioned2014-02-13T10:00:00Z
dc.date.available2014-02-13T10:00:00Z
dc.date.issued2013-02
dc.identifier.urihttp://hdl.handle.net/11250/166770
dc.description.abstractWe study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies’ substitution incentives are determined by relative margins and relative patient copayments. Second, we exploit a unique product level panel data set, which contains information on sales and prices at both producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand-names and generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales.no_NO
dc.language.isoengno_NO
dc.publisherSNFno_NO
dc.relation.ispartofseriesWorking paper;08/13
dc.subjectpharmaceuticalsno_NO
dc.subjectpharmaciesno_NO
dc.subjectgeneric substitutionno_NO
dc.titleMargins and market shares : pharmacy incentives for generic substitutionno_NO
dc.typeWorking paperno_NO
dc.subject.nsiVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Pharmacology: 728no_NO
dc.subject.nsiVDP::Social science: 200::Economics: 210::Economics: 212no_NO


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel